4//SEC Filing
Boyd Taylor 4
Accession 0002090172-25-000002
CIK 0001534120other
Filed
Oct 5, 8:00 PM ET
Accepted
Oct 6, 4:28 PM ET
Size
5.7 KB
Accession
0002090172-25-000002
Insider Transaction Report
Form 4
Boyd Taylor
Chief Business Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-10-01+275,000→ 275,000 totalExercise: $12.96Exp: 2035-10-01→ Common Stock (275,000 underlying)
Footnotes (1)
- [F1]The stock option was granted on October 1, 2025, and vests over four years, with the first 25% vesting on the first anniversary of the grant date and the remainder vesting in equal monthly installments over the following three years, subject to the reporting person's continued employment with the Company on each applicable vesting date.
Documents
Issuer
Avalo Therapeutics, Inc.
CIK 0001534120
Entity typeother
Related Parties
1- filerCIK 0002090172
Filing Metadata
- Form type
- 4
- Filed
- Oct 5, 8:00 PM ET
- Accepted
- Oct 6, 4:28 PM ET
- Size
- 5.7 KB